Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02408692 · ClinicalTrials.gov registry record · Phase 4

Emergency Contraception and Body Weight: Pilot Study

A Phase 4 study, sponsored by Oregon Health and Science University.

Completed
Registry status
Phase 4
Development phase
10
Enrollment target

NCT02408692: Completed Phase 4 study, sponsored by Oregon Health and Science University.

NCT02408692 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02408692, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
Phase 4
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this research study is to determine how body weight changes the drug level of an emergency contraceptive pill containing a hormone called levonorgestrel (LNG). This emergency contraceptive is available to women without a prescription, but has recently been found to not work as well to prevent pregnancies in women of higher body weight. The overall goal of this research is to improve the effectiveness of contraception for women, no matter their weight.

Primary Outcome

Pharmacokinetic sampling at 0, 0.5, 1, 1.5, 2, and 2.5 hours were performed after ingestion of 1.5mg of levonorgestrel

Interventions

  • DRUG ECx1
  • DRUG ECx2

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2015-02
Est. Completion 2015-08
Phase Phase 4

What the finished NCT02408692 record still lists

NCT02408692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which ECx1 is the first listed.

NCT02408692 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02408692 about?

NCT02408692 is a clinical study titled "Emergency Contraception and Body Weight: Pilot Study". The purpose of this research study is to determine how body weight changes the drug level of an emergency contraceptive pill containing a hormone called levonorgestrel (LNG). This emergency contraceptive is available to women without a prescription, but has recently been found to not work as well to...

What is the current status of trial NCT02408692?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2015-02. Estimated completion is 2015-08.

What interventions are being tested in trial NCT02408692?

The interventions under investigation include: ECx1 (DRUG), ECx2 (DRUG).

Who is sponsoring clinical trial NCT02408692?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02408692's enrollment target sits among peer trials

10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02408692, the US trial registry maintained by the National Library of Medicine. NCT02408692 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.